Package 78206-162-01

Brand: renflexis

Generic: infliximab
NDC Package

Package Facts

Identity

Package NDC 78206-162-01
Digits Only 7820616201
Product NDC 78206-162
Product ID 78206-162_ae5aa866-45c5-4dd8-ace4-cabe72994604
Description

1 VIAL in 1 CARTON (78206-162-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (78206-162-99)

Marketing

Marketing Status
Marketed Since 2021-06-01
Brand renflexis
Generic infliximab
Sample Package No

Linked Drug Pages (1)

Renflexis ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "ae5aa866-45c5-4dd8-ace4-cabe72994604", "openfda": {"nui": ["N0000175610", "N0000175451"], "unii": ["B72HH48FLU"], "rxcui": ["1927285", "1927290"], "spl_set_id": ["dbf738c4-3fac-4422-a9d8-51d9c83a8789"], "pharm_class_epc": ["Tumor Necrosis Factor Blocker [EPC]"], "pharm_class_moa": ["Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "manufacturer_name": ["Organon LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (78206-162-01)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL (78206-162-99)", "package_ndc": "78206-162-01", "marketing_start_date": "20210601"}], "brand_name": "Renflexis", "product_id": "78206-162_ae5aa866-45c5-4dd8-ace4-cabe72994604", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Tumor Necrosis Factor Blocker [EPC]", "Tumor Necrosis Factor Receptor Blocking Activity [MoA]"], "product_ndc": "78206-162", "generic_name": "infliximab", "labeler_name": "Organon LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Renflexis", "active_ingredients": [{"name": "INFLIXIMAB", "strength": "100 mg/1"}], "application_number": "BLA761054", "marketing_category": "BLA", "marketing_start_date": "20170421", "listing_expiration_date": "20261231"}